Skip to main content
Clinical Trials/NCT04985630
NCT04985630RecruitingNot Applicable

Open-labelled Study to Validate Home-based Use of a Health and Wellness Kit (The Mitopure Challenge) to Detect Levels of Urolithin A in Dried Blood Spots After Intake of Mitopure (Proprietary Urolithin A)

Amazentis SA1 site in 1 country250 target enrollmentStarted: August 30, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
250
Locations
1
Primary Endpoint
Failure/rejection rate (% of the samples) collected at home by participants.

Study Overview

Brief Summary

Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Males and females 18 to 80 years of age;
  • •Is in general good health, as determined by the research team;
  • •Willingness to consume the investigation product, complete questionnaires and to complete the study;
  • •Have given voluntary, electronic, informed consent to be a participant in the study.

Exclusion Criteria

  • •Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial;
  • •Volunteers who plan to donate blood during the study or within 30 days of completing the study;
  • •Subject has a known allergy to the test material's active or inactive ingredients;
  • •Subjects with unstable medical conditions;
  • •Participation in a clinical research trial within 30 days prior to randomization;
  • •Allergy or sensitivity to study ingredients;
  • •Individuals who are cognitively impaired and/or who are unable to give informed consent;
  • •Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject;
  • •Has taken antibiotics within the previous 30 days.

Arms & Interventions

Mitopure Challenge to assess blood levels of Urolithin A after dietary and Mitopure intake

Experimental

Mitopure challenge with diet (Pomegranate juice- Before) followed by Mitopure supplementation (After) to compare levels in blood spots of UA-Glucuronide (in ng/mL)

Intervention: Pomegranate Juice (Dietary Supplement)

Mitopure Challenge to assess blood levels of Urolithin A after dietary and Mitopure intake

Experimental

Mitopure challenge with diet (Pomegranate juice- Before) followed by Mitopure supplementation (After) to compare levels in blood spots of UA-Glucuronide (in ng/mL)

Intervention: Mitopure (Dietary Supplement)

Outcomes

Primary Outcomes

Failure/rejection rate (% of the samples) collected at home by participants.

Time Frame: 4 weeks

Acceptability target goal is to hit 80% of analyzed samples

Secondary Outcomes

  • Sensitivity and specificity (% of the samples) of the analytical method developed to test Urolithin A in dry blood spots.(4 weeks)
  • Validation of a health questionnaire on participants health status(4 weeks)
  • Fold change increase in the levels of UA-Glucuronide (in ng/mL) in the dried blood spots provided in the kit before and after the challenge(4 weeks)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials